OncoArendi to evaluate OATD-01 in Phase I trial for asthma

Polish biopharmaceutical company OncoArendi Therapeutics is set to conduct a Phase I clinical trial of its lead drug candidate OATD-01 to treat patients suffering from asthma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news